Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Saimiri | 67 | 2024 | 337 | 4.020 |
Why?
|
Behavior, Animal | 39 | 2024 | 1882 | 3.940 |
Why?
|
Discrimination Learning | 27 | 2021 | 278 | 3.630 |
Why?
|
Cocaine | 41 | 2021 | 960 | 2.850 |
Why?
|
Methamphetamine | 13 | 2021 | 167 | 2.570 |
Why?
|
Conditioning, Operant | 22 | 2021 | 311 | 2.240 |
Why?
|
Nicotine | 8 | 2019 | 681 | 2.190 |
Why?
|
Receptor, Cannabinoid, CB1 | 10 | 2020 | 137 | 2.120 |
Why?
|
Receptors, Dopamine D1 | 20 | 2007 | 292 | 2.050 |
Why?
|
Central Nervous System Stimulants | 14 | 2024 | 1180 | 1.720 |
Why?
|
Nicotinic Agonists | 5 | 2021 | 266 | 1.640 |
Why?
|
Dopamine Agonists | 17 | 2012 | 353 | 1.610 |
Why?
|
Dopamine Agents | 9 | 2014 | 190 | 1.590 |
Why?
|
Self Administration | 31 | 2024 | 387 | 1.580 |
Why?
|
Dose-Response Relationship, Drug | 59 | 2024 | 10784 | 1.440 |
Why?
|
Behavior, Addictive | 7 | 2019 | 467 | 1.400 |
Why?
|
Dopamine Uptake Inhibitors | 12 | 2019 | 298 | 1.330 |
Why?
|
Benzazepines | 17 | 2018 | 311 | 1.300 |
Why?
|
Substance Withdrawal Syndrome | 5 | 2019 | 628 | 1.280 |
Why?
|
Dopamine Antagonists | 12 | 2015 | 289 | 1.270 |
Why?
|
Cannabinoids | 6 | 2022 | 173 | 1.270 |
Why?
|
Receptors, Dopamine D2 | 13 | 2008 | 486 | 1.230 |
Why?
|
Macaca mulatta | 26 | 2024 | 2362 | 1.190 |
Why?
|
Reversal Learning | 4 | 2016 | 57 | 1.180 |
Why?
|
Analgesics, Opioid | 11 | 2024 | 3837 | 1.070 |
Why?
|
Naltrexone | 8 | 2024 | 319 | 1.040 |
Why?
|
Food | 7 | 2019 | 770 | 1.030 |
Why?
|
Substance-Related Disorders | 15 | 2019 | 4453 | 1.010 |
Why?
|
Receptors, Opioid, mu | 9 | 2024 | 171 | 0.940 |
Why?
|
Alkaloids | 4 | 2021 | 192 | 0.940 |
Why?
|
Receptors, Dopamine D4 | 2 | 2015 | 169 | 0.850 |
Why?
|
Animals | 142 | 2024 | 169424 | 0.840 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 9 | 2006 | 54 | 0.840 |
Why?
|
Reinforcement Schedule | 17 | 2017 | 123 | 0.800 |
Why?
|
Buspirone | 2 | 2012 | 80 | 0.790 |
Why?
|
Drug Interactions | 18 | 2020 | 1421 | 0.770 |
Why?
|
Biology | 1 | 2023 | 291 | 0.750 |
Why?
|
Cocaine-Related Disorders | 9 | 2019 | 461 | 0.720 |
Why?
|
Arachidonic Acids | 4 | 2020 | 296 | 0.670 |
Why?
|
Amphetamine-Related Disorders | 2 | 2018 | 81 | 0.650 |
Why?
|
Pharmacology | 4 | 2021 | 98 | 0.650 |
Why?
|
Endocannabinoids | 3 | 2017 | 113 | 0.650 |
Why?
|
Narcotic Antagonists | 6 | 2024 | 590 | 0.640 |
Why?
|
Piperidines | 7 | 2022 | 1664 | 0.640 |
Why?
|
Drug-Seeking Behavior | 6 | 2024 | 46 | 0.620 |
Why?
|
Cannabidiol | 2 | 2021 | 123 | 0.620 |
Why?
|
Disulfiram | 1 | 2018 | 63 | 0.610 |
Why?
|
Cannabinol | 3 | 2017 | 9 | 0.600 |
Why?
|
Heroin | 1 | 2018 | 120 | 0.590 |
Why?
|
Cognition | 8 | 2024 | 7062 | 0.590 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2021 | 371 | 0.580 |
Why?
|
Neuroimmunomodulation | 1 | 2019 | 188 | 0.570 |
Why?
|
Psychomotor Performance | 5 | 2021 | 1894 | 0.570 |
Why?
|
Polyunsaturated Alkamides | 2 | 2017 | 29 | 0.560 |
Why?
|
Pyrazoles | 7 | 2022 | 2024 | 0.560 |
Why?
|
Vaccines | 2 | 2016 | 845 | 0.540 |
Why?
|
Behavior | 5 | 2021 | 545 | 0.540 |
Why?
|
Nitrates | 1 | 2018 | 260 | 0.530 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 188 | 0.530 |
Why?
|
Computers, Handheld | 1 | 2017 | 211 | 0.510 |
Why?
|
Drug Discovery | 1 | 2023 | 1062 | 0.500 |
Why?
|
Receptors, Dopamine D3 | 2 | 2012 | 108 | 0.490 |
Why?
|
Receptors, Nicotinic | 2 | 2018 | 494 | 0.470 |
Why?
|
Eating | 5 | 2018 | 1538 | 0.470 |
Why?
|
Touch | 2 | 2017 | 316 | 0.470 |
Why?
|
Smoke | 1 | 2016 | 236 | 0.450 |
Why?
|
Psychopharmacology | 3 | 2009 | 146 | 0.450 |
Why?
|
Wakefulness | 5 | 2024 | 1280 | 0.440 |
Why?
|
Dopamine | 7 | 2018 | 1616 | 0.420 |
Why?
|
Adamantane | 2 | 2017 | 148 | 0.410 |
Why?
|
Nucleus Accumbens | 4 | 2024 | 372 | 0.410 |
Why?
|
Selegiline | 3 | 2005 | 32 | 0.410 |
Why?
|
Reaction Time | 8 | 2021 | 2102 | 0.400 |
Why?
|
Psychology | 1 | 2014 | 356 | 0.400 |
Why?
|
Neuropsychological Tests | 3 | 2021 | 7133 | 0.380 |
Why?
|
Serotonin Receptor Agonists | 1 | 2012 | 151 | 0.380 |
Why?
|
Pyrrolidines | 6 | 2021 | 341 | 0.380 |
Why?
|
Male | 93 | 2024 | 364761 | 0.380 |
Why?
|
Biogenic Monoamines | 2 | 2010 | 51 | 0.370 |
Why?
|
Fentanyl | 3 | 2024 | 450 | 0.360 |
Why?
|
Tobacco Use Disorder | 2 | 2016 | 710 | 0.360 |
Why?
|
Blinking | 3 | 2007 | 134 | 0.360 |
Why?
|
Immunization | 1 | 2015 | 1220 | 0.360 |
Why?
|
Amphetamines | 2 | 2005 | 144 | 0.350 |
Why?
|
Cholinergic Agents | 1 | 2010 | 97 | 0.350 |
Why?
|
Receptors, Opioid | 5 | 2022 | 145 | 0.350 |
Why?
|
Pain Threshold | 1 | 2014 | 606 | 0.350 |
Why?
|
Nanotechnology | 1 | 2016 | 714 | 0.340 |
Why?
|
Anti-Anxiety Agents | 1 | 2012 | 405 | 0.340 |
Why?
|
Diuretics | 1 | 2012 | 612 | 0.330 |
Why?
|
Membrane Transport Proteins | 3 | 2017 | 1036 | 0.330 |
Why?
|
Psychotropic Drugs | 3 | 2021 | 888 | 0.320 |
Why?
|
Buprenorphine | 3 | 2019 | 661 | 0.320 |
Why?
|
GABA-A Receptor Agonists | 4 | 2003 | 86 | 0.320 |
Why?
|
Methylphenidate | 5 | 2024 | 491 | 0.310 |
Why?
|
Behavioral Research | 1 | 2008 | 52 | 0.300 |
Why?
|
Morphinans | 2 | 2023 | 27 | 0.300 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 749 | 0.300 |
Why?
|
Reward | 4 | 2024 | 987 | 0.290 |
Why?
|
Drug Tolerance | 6 | 2021 | 367 | 0.290 |
Why?
|
Opioid-Related Disorders | 5 | 2024 | 2188 | 0.290 |
Why?
|
Drug Partial Agonism | 2 | 2019 | 24 | 0.280 |
Why?
|
Receptors, Opioid, kappa | 5 | 2007 | 138 | 0.280 |
Why?
|
Pyridines | 4 | 2021 | 2888 | 0.270 |
Why?
|
Electroshock | 7 | 2012 | 120 | 0.270 |
Why?
|
Choice Behavior | 3 | 2015 | 846 | 0.270 |
Why?
|
Drug Delivery Systems | 2 | 2016 | 2238 | 0.270 |
Why?
|
Ligands | 8 | 2022 | 3279 | 0.260 |
Why?
|
Muscarinic Antagonists | 2 | 2021 | 135 | 0.260 |
Why?
|
Motor Activity | 3 | 2017 | 2722 | 0.260 |
Why?
|
Drug Synergism | 2 | 2021 | 1765 | 0.260 |
Why?
|
Piperazines | 6 | 2010 | 2546 | 0.260 |
Why?
|
Immunologic Factors | 1 | 2015 | 1600 | 0.250 |
Why?
|
Dextroamphetamine | 6 | 2010 | 134 | 0.250 |
Why?
|
Rats, Long-Evans | 2 | 2024 | 380 | 0.250 |
Why?
|
Quinolones | 1 | 2008 | 382 | 0.250 |
Why?
|
Benzofurans | 2 | 2007 | 139 | 0.240 |
Why?
|
Rats | 16 | 2024 | 23839 | 0.240 |
Why?
|
Oxycodone | 3 | 2024 | 142 | 0.240 |
Why?
|
Amphetamine | 4 | 2020 | 224 | 0.240 |
Why?
|
Nicotinic Antagonists | 2 | 2018 | 94 | 0.240 |
Why?
|
Disease Models, Animal | 6 | 2019 | 18390 | 0.240 |
Why?
|
Electroencephalography | 5 | 2024 | 6309 | 0.240 |
Why?
|
Membrane Transport Modulators | 1 | 2004 | 24 | 0.240 |
Why?
|
Motivation | 4 | 2024 | 2034 | 0.230 |
Why?
|
Nalbuphine | 2 | 2021 | 20 | 0.230 |
Why?
|
Receptors, Opioid, delta | 2 | 2022 | 48 | 0.230 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2021 | 69 | 0.220 |
Why?
|
Smoking Cessation | 1 | 2016 | 2078 | 0.220 |
Why?
|
Phenethylamines | 2 | 2001 | 95 | 0.220 |
Why?
|
Morphine | 6 | 2023 | 658 | 0.220 |
Why?
|
Periodicals as Topic | 2 | 2020 | 1468 | 0.220 |
Why?
|
Midazolam | 3 | 2003 | 267 | 0.220 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3710 | 0.210 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2021 | 419 | 0.210 |
Why?
|
Rats, Sprague-Dawley | 9 | 2021 | 8201 | 0.210 |
Why?
|
Pain | 3 | 2020 | 5096 | 0.210 |
Why?
|
Oxazines | 5 | 2004 | 357 | 0.200 |
Why?
|
Psychophysiology | 1 | 2002 | 137 | 0.200 |
Why?
|
Narcotics | 2 | 1996 | 337 | 0.200 |
Why?
|
Receptor, Serotonin, 5-HT2C | 2 | 2018 | 42 | 0.190 |
Why?
|
History, 20th Century | 4 | 2014 | 2772 | 0.190 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2019 | 1339 | 0.190 |
Why?
|
Brain | 11 | 2024 | 27439 | 0.190 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2001 | 154 | 0.190 |
Why?
|
Monoamine Oxidase | 1 | 2001 | 183 | 0.180 |
Why?
|
Scopolamine | 1 | 2021 | 93 | 0.180 |
Why?
|
Injections, Intramuscular | 5 | 2017 | 557 | 0.180 |
Why?
|
Levorphanol | 4 | 2010 | 9 | 0.180 |
Why?
|
GABA Agonists | 1 | 2000 | 104 | 0.180 |
Why?
|
Microdialysis | 3 | 2017 | 163 | 0.180 |
Why?
|
Adrenergic Uptake Inhibitors | 2 | 2015 | 186 | 0.170 |
Why?
|
Callithrix | 2 | 2021 | 95 | 0.170 |
Why?
|
Drug Design | 2 | 2014 | 1050 | 0.170 |
Why?
|
Hydromorphone | 1 | 2020 | 70 | 0.170 |
Why?
|
Receptors, GABA-A | 2 | 2001 | 626 | 0.170 |
Why?
|
Behavioral Medicine | 1 | 2020 | 49 | 0.170 |
Why?
|
Inflammation | 1 | 2019 | 10863 | 0.170 |
Why?
|
Structure-Activity Relationship | 7 | 2020 | 3074 | 0.170 |
Why?
|
Rodentia | 1 | 2021 | 262 | 0.170 |
Why?
|
Acetamides | 1 | 2001 | 260 | 0.170 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2021 | 328 | 0.170 |
Why?
|
Benzopyrans | 1 | 2019 | 63 | 0.170 |
Why?
|
Scalp | 1 | 2022 | 392 | 0.160 |
Why?
|
Catalepsy | 2 | 1998 | 31 | 0.160 |
Why?
|
Antidepressive Agents | 2 | 2021 | 2913 | 0.160 |
Why?
|
Hypercapnia | 1 | 2020 | 260 | 0.160 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2021 | 452 | 0.160 |
Why?
|
Antiemetics | 1 | 2020 | 188 | 0.150 |
Why?
|
Evoked Potentials | 1 | 2024 | 1057 | 0.150 |
Why?
|
Binding, Competitive | 7 | 2020 | 1144 | 0.150 |
Why?
|
Feeding Behavior | 5 | 2016 | 3202 | 0.150 |
Why?
|
Injections, Intravenous | 5 | 2017 | 1379 | 0.150 |
Why?
|
Self Stimulation | 1 | 2017 | 47 | 0.150 |
Why?
|
Neuropeptides | 1 | 2003 | 950 | 0.150 |
Why?
|
Caffeine | 1 | 2002 | 702 | 0.150 |
Why?
|
Primates | 4 | 2022 | 523 | 0.150 |
Why?
|
Acetylcysteine | 1 | 2019 | 262 | 0.150 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2017 | 66 | 0.140 |
Why?
|
Clozapine | 3 | 1997 | 508 | 0.140 |
Why?
|
Monoacylglycerol Lipases | 1 | 2017 | 37 | 0.140 |
Why?
|
Corpus Striatum | 1 | 2024 | 1238 | 0.140 |
Why?
|
Ethylketocyclazocine | 2 | 2007 | 4 | 0.140 |
Why?
|
Histamine H1 Antagonists | 2 | 1988 | 101 | 0.140 |
Why?
|
Hallucinogens | 1 | 2021 | 208 | 0.140 |
Why?
|
Racemases and Epimerases | 1 | 2017 | 114 | 0.140 |
Why?
|
Serotonin | 3 | 2017 | 1047 | 0.140 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2018 | 92 | 0.140 |
Why?
|
Drug Industry | 1 | 2003 | 793 | 0.140 |
Why?
|
Drug Substitution | 1 | 2019 | 291 | 0.140 |
Why?
|
Amidohydrolases | 1 | 2017 | 160 | 0.140 |
Why?
|
Receptors, Cannabinoid | 1 | 2016 | 43 | 0.140 |
Why?
|
Pain Measurement | 2 | 2019 | 3577 | 0.130 |
Why?
|
Analysis of Variance | 3 | 2015 | 6242 | 0.130 |
Why?
|
Anabasine | 1 | 2016 | 6 | 0.130 |
Why?
|
Recurrence | 3 | 2024 | 8510 | 0.130 |
Why?
|
Respiratory Insufficiency | 2 | 2022 | 1244 | 0.130 |
Why?
|
Drugs, Investigational | 1 | 2017 | 213 | 0.120 |
Why?
|
Analgesics | 3 | 2013 | 1070 | 0.120 |
Why?
|
Locomotion | 1 | 2018 | 391 | 0.120 |
Why?
|
Cotinine | 1 | 2016 | 207 | 0.120 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 666 | 0.120 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 939 | 0.120 |
Why?
|
Naphthalenes | 2 | 2013 | 198 | 0.120 |
Why?
|
Ketamine | 1 | 2021 | 524 | 0.120 |
Why?
|
Berberine | 1 | 2015 | 26 | 0.120 |
Why?
|
Photic Stimulation | 3 | 2021 | 2005 | 0.120 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 3 | 2010 | 20 | 0.120 |
Why?
|
Carbamates | 1 | 2016 | 192 | 0.120 |
Why?
|
Humans | 45 | 2024 | 768369 | 0.120 |
Why?
|
Benzoxazines | 2 | 2013 | 321 | 0.110 |
Why?
|
Tetrahydroisoquinolines | 1 | 1994 | 81 | 0.110 |
Why?
|
Respiration | 3 | 1996 | 1667 | 0.110 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2013 | 49 | 0.110 |
Why?
|
Phencyclidine | 2 | 2021 | 60 | 0.110 |
Why?
|
Kynurenic Acid | 1 | 2013 | 44 | 0.110 |
Why?
|
Benzodiazepines | 2 | 1999 | 1139 | 0.110 |
Why?
|
Kinetics | 2 | 2018 | 6347 | 0.110 |
Why?
|
Nerve Tissue Proteins | 2 | 2017 | 4417 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2001 | 1188 | 0.110 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 840 | 0.110 |
Why?
|
Appetite Stimulants | 1 | 2012 | 14 | 0.110 |
Why?
|
Chlorpheniramine | 2 | 1990 | 13 | 0.110 |
Why?
|
Stereoisomerism | 4 | 2006 | 612 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4861 | 0.100 |
Why?
|
Morpholines | 2 | 2013 | 583 | 0.100 |
Why?
|
Overnutrition | 1 | 2012 | 25 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 712 | 0.100 |
Why?
|
Diuresis | 1 | 2012 | 106 | 0.100 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2012 | 62 | 0.100 |
Why?
|
Pentobarbital | 2 | 2010 | 153 | 0.100 |
Why?
|
Butyrylcholinesterase | 1 | 2012 | 21 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 905 | 0.100 |
Why?
|
HEK293 Cells | 4 | 2016 | 4294 | 0.100 |
Why?
|
Tritium | 1 | 2012 | 707 | 0.100 |
Why?
|
Appetite Depressants | 1 | 2012 | 108 | 0.100 |
Why?
|
Antipsychotic Agents | 3 | 2008 | 3077 | 0.100 |
Why?
|
Memory, Short-Term | 2 | 2016 | 1008 | 0.100 |
Why?
|
Basal Ganglia | 1 | 2015 | 555 | 0.100 |
Why?
|
Neural Pathways | 4 | 2024 | 3122 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1409 | 0.090 |
Why?
|
Oxytocin | 1 | 2015 | 402 | 0.090 |
Why?
|
Haloperidol | 2 | 1994 | 394 | 0.090 |
Why?
|
Mecamylamine | 1 | 2010 | 27 | 0.090 |
Why?
|
CHO Cells | 3 | 2022 | 1382 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 36840 | 0.090 |
Why?
|
Benzodioxoles | 2 | 2021 | 75 | 0.090 |
Why?
|
Neurotransmitter Uptake Inhibitors | 2 | 1989 | 36 | 0.090 |
Why?
|
Physical Stimulation | 1 | 2012 | 517 | 0.090 |
Why?
|
Flumazenil | 2 | 2001 | 84 | 0.090 |
Why?
|
Naloxone | 3 | 1996 | 371 | 0.090 |
Why?
|
Propiophenones | 3 | 2021 | 28 | 0.090 |
Why?
|
Learning | 2 | 2020 | 1762 | 0.090 |
Why?
|
Desipramine | 3 | 2005 | 183 | 0.090 |
Why?
|
Benzomorphans | 2 | 1989 | 5 | 0.090 |
Why?
|
Chlordiazepoxide | 2 | 1986 | 42 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2674 | 0.090 |
Why?
|
Diazepam | 3 | 2003 | 215 | 0.090 |
Why?
|
Protein Binding | 4 | 2021 | 9376 | 0.090 |
Why?
|
Central Nervous System Agents | 1 | 2010 | 74 | 0.090 |
Why?
|
Benzamides | 1 | 2016 | 1381 | 0.090 |
Why?
|
Cricetinae | 3 | 2022 | 2423 | 0.090 |
Why?
|
Body Temperature | 1 | 2012 | 781 | 0.080 |
Why?
|
Female | 25 | 2024 | 396926 | 0.080 |
Why?
|
Albumins | 1 | 2012 | 578 | 0.080 |
Why?
|
Kwashiorkor | 1 | 1988 | 24 | 0.080 |
Why?
|
Pyrimidines | 1 | 2001 | 3050 | 0.080 |
Why?
|
Mice | 10 | 2022 | 82051 | 0.080 |
Why?
|
Social Behavior | 1 | 2015 | 1144 | 0.080 |
Why?
|
Cholinesterase Inhibitors | 1 | 2010 | 242 | 0.080 |
Why?
|
Genetics, Behavioral | 1 | 2008 | 53 | 0.080 |
Why?
|
Norepinephrine | 2 | 2017 | 900 | 0.080 |
Why?
|
Quinoxalines | 1 | 2010 | 297 | 0.080 |
Why?
|
Carbolines | 2 | 2001 | 296 | 0.080 |
Why?
|
Avoidance Learning | 1 | 2010 | 249 | 0.080 |
Why?
|
Extracellular Space | 1 | 2010 | 565 | 0.070 |
Why?
|
Haplorhini | 1 | 2008 | 524 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2022 | 3984 | 0.070 |
Why?
|
Hot Temperature | 1 | 2014 | 1438 | 0.070 |
Why?
|
Extinction, Psychological | 2 | 2019 | 371 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3734 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2932 | 0.070 |
Why?
|
Cyclazocine | 1 | 1985 | 10 | 0.070 |
Why?
|
Water | 1 | 2012 | 1421 | 0.070 |
Why?
|
Generalization, Stimulus | 1 | 2005 | 13 | 0.070 |
Why?
|
Phenanthridines | 2 | 1996 | 51 | 0.060 |
Why?
|
Molecular Structure | 3 | 2016 | 1889 | 0.060 |
Why?
|
Nalorphine | 1 | 1985 | 5 | 0.060 |
Why?
|
Attention | 1 | 2016 | 2423 | 0.060 |
Why?
|
History, 21st Century | 1 | 2011 | 1575 | 0.060 |
Why?
|
Morphine Dependence | 1 | 1985 | 27 | 0.060 |
Why?
|
GABA Modulators | 2 | 2003 | 109 | 0.060 |
Why?
|
Heart Rate | 3 | 2021 | 4218 | 0.060 |
Why?
|
Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 9 | 0.060 |
Why?
|
Association Learning | 1 | 2005 | 223 | 0.060 |
Why?
|
Chlorides | 1 | 1986 | 663 | 0.060 |
Why?
|
Lithium | 1 | 1986 | 600 | 0.050 |
Why?
|
Mental Disorders | 2 | 2019 | 6879 | 0.050 |
Why?
|
Nanoparticles | 1 | 2015 | 1986 | 0.050 |
Why?
|
Neurons | 2 | 2024 | 9504 | 0.050 |
Why?
|
Conditioning, Classical | 1 | 2005 | 370 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4816 | 0.050 |
Why?
|
Probability Learning | 1 | 2021 | 23 | 0.050 |
Why?
|
GABA Antagonists | 1 | 2001 | 119 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2003 | 585 | 0.050 |
Why?
|
Pentanones | 1 | 2021 | 12 | 0.050 |
Why?
|
Time Factors | 4 | 2015 | 40271 | 0.050 |
Why?
|
Tremor | 1 | 2022 | 193 | 0.050 |
Why?
|
Salivation | 1 | 2020 | 22 | 0.040 |
Why?
|
Citalopram | 1 | 2003 | 403 | 0.040 |
Why?
|
Receptors, Dopamine | 2 | 1991 | 296 | 0.040 |
Why?
|
Receptors, Muscarinic | 1 | 2021 | 157 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2018 | 65408 | 0.040 |
Why?
|
Tetrahydronaphthalenes | 1 | 2000 | 86 | 0.040 |
Why?
|
Species Specificity | 1 | 2024 | 2419 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 1999 | 50 | 0.040 |
Why?
|
Swimming | 1 | 2021 | 209 | 0.040 |
Why?
|
GABA-A Receptor Antagonists | 1 | 1999 | 59 | 0.040 |
Why?
|
Cues | 2 | 2016 | 884 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
Behavioral Sciences | 1 | 2019 | 29 | 0.040 |
Why?
|
Cricetulus | 1 | 2021 | 815 | 0.040 |
Why?
|
Rest | 1 | 2024 | 952 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2014 | 4538 | 0.040 |
Why?
|
Schizophrenia | 1 | 2017 | 6987 | 0.040 |
Why?
|
Sleep, REM | 1 | 2022 | 595 | 0.040 |
Why?
|
Evoked Potentials, Visual | 1 | 2021 | 420 | 0.040 |
Why?
|
Ergolines | 1 | 1998 | 57 | 0.040 |
Why?
|
Drug Agonism | 1 | 2017 | 2 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2019 | 212 | 0.040 |
Why?
|
Adrenergic Agents | 1 | 1998 | 73 | 0.040 |
Why?
|
Infusions, Subcutaneous | 1 | 2017 | 43 | 0.040 |
Why?
|
Drug Antagonism | 1 | 2017 | 51 | 0.040 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2017 | 31 | 0.040 |
Why?
|
Glycerides | 1 | 2017 | 67 | 0.040 |
Why?
|
Binding Sites | 3 | 1999 | 6029 | 0.040 |
Why?
|
United States | 3 | 2014 | 73120 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2018 | 370 | 0.040 |
Why?
|
Models, Molecular | 2 | 2020 | 5441 | 0.040 |
Why?
|
Brain Mapping | 2 | 2024 | 6740 | 0.030 |
Why?
|
Imidazoles | 1 | 2003 | 1174 | 0.030 |
Why?
|
Bupropion | 2 | 1989 | 304 | 0.030 |
Why?
|
Vomiting | 1 | 2020 | 655 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2021 | 771 | 0.030 |
Why?
|
Thiophenes | 1 | 2001 | 570 | 0.030 |
Why?
|
Codeine | 1 | 1996 | 51 | 0.030 |
Why?
|
Psychiatry | 1 | 2008 | 1714 | 0.030 |
Why?
|
Arousal | 1 | 2022 | 1182 | 0.030 |
Why?
|
Executive Function | 1 | 2024 | 1402 | 0.030 |
Why?
|
Myocardium | 1 | 1988 | 4789 | 0.030 |
Why?
|
Rats, Wistar | 1 | 1999 | 1891 | 0.030 |
Why?
|
Receptors, Drug | 2 | 1992 | 157 | 0.030 |
Why?
|
Pyrroles | 1 | 2001 | 1127 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2126 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2020 | 1136 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1993 | 306 | 0.030 |
Why?
|
Flupenthixol | 1 | 1993 | 11 | 0.030 |
Why?
|
Serine | 1 | 2017 | 831 | 0.030 |
Why?
|
Cannabis | 1 | 2020 | 444 | 0.030 |
Why?
|
Salicylamides | 1 | 1993 | 33 | 0.030 |
Why?
|
Carbon Dioxide | 2 | 1996 | 1152 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1706 | 0.030 |
Why?
|
Autoantigens | 1 | 2017 | 893 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2003 | 1923 | 0.030 |
Why?
|
Isoquinolines | 1 | 1994 | 354 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2018 | 14483 | 0.030 |
Why?
|
Drug Therapy | 1 | 2015 | 504 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2017 | 1192 | 0.020 |
Why?
|
Nerve Net | 1 | 2024 | 2362 | 0.020 |
Why?
|
Marijuana Abuse | 1 | 2016 | 412 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 1629 | 0.020 |
Why?
|
Indans | 1 | 1992 | 92 | 0.020 |
Why?
|
Biocatalysis | 1 | 2012 | 170 | 0.020 |
Why?
|
Analgesia | 1 | 1996 | 461 | 0.020 |
Why?
|
Radioligand Assay | 1 | 1991 | 366 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2017 | 1140 | 0.020 |
Why?
|
Hemodynamics | 1 | 2002 | 4202 | 0.020 |
Why?
|
Personality | 1 | 2014 | 558 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 650 | 0.020 |
Why?
|
Pyrilamine | 1 | 1990 | 13 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1439 | 0.020 |
Why?
|
Posture | 1 | 1994 | 956 | 0.020 |
Why?
|
Mazindol | 1 | 1989 | 13 | 0.020 |
Why?
|
Nomifensine | 1 | 1989 | 14 | 0.020 |
Why?
|
Astrocytes | 1 | 2018 | 1354 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 3742 | 0.020 |
Why?
|
Fear | 1 | 2018 | 1494 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2723 | 0.020 |
Why?
|
Cyproheptadine | 1 | 1988 | 21 | 0.020 |
Why?
|
Head | 1 | 1994 | 927 | 0.020 |
Why?
|
Putamen | 1 | 1989 | 292 | 0.020 |
Why?
|
Carrier Proteins | 2 | 1992 | 4948 | 0.020 |
Why?
|
Depression | 2 | 2021 | 8235 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 1989 | 391 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9508 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12450 | 0.020 |
Why?
|
Heart Septum | 1 | 1988 | 304 | 0.020 |
Why?
|
Movement | 1 | 1994 | 1489 | 0.020 |
Why?
|
Antibody Formation | 1 | 2012 | 1393 | 0.020 |
Why?
|
Tripelennamine | 1 | 1986 | 6 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10647 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2013 | 1479 | 0.020 |
Why?
|
Promethazine | 1 | 1986 | 29 | 0.020 |
Why?
|
Cimetidine | 1 | 1986 | 76 | 0.020 |
Why?
|
Indoles | 1 | 1995 | 1834 | 0.020 |
Why?
|
Molecular Biology | 1 | 2010 | 573 | 0.020 |
Why?
|
Child Behavior | 1 | 2012 | 862 | 0.020 |
Why?
|
Diphenhydramine | 1 | 1986 | 63 | 0.020 |
Why?
|
Lithium Chloride | 1 | 1986 | 83 | 0.020 |
Why?
|
Phenazocine | 1 | 1985 | 7 | 0.020 |
Why?
|
Sleep | 1 | 2022 | 4796 | 0.020 |
Why?
|
Thiazoles | 1 | 2013 | 1541 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3783 | 0.020 |
Why?
|
Propylamines | 1 | 2005 | 162 | 0.010 |
Why?
|
Infusion Pumps | 1 | 2005 | 163 | 0.010 |
Why?
|
Adolescent Behavior | 1 | 2012 | 1192 | 0.010 |
Why?
|
Sulfonamides | 1 | 2013 | 1988 | 0.010 |
Why?
|
Nordazepam | 1 | 2003 | 5 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 1988 | 1527 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 2012 | 1363 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20232 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10601 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1448 | 0.010 |
Why?
|
Adult | 3 | 2024 | 223528 | 0.010 |
Why?
|
Food Deprivation | 1 | 1981 | 114 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3832 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8559 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16712 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22365 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2003 | 1543 | 0.010 |
Why?
|
Blood Pressure | 2 | 2007 | 8537 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 60038 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2014 | 4636 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1988 | 3839 | 0.010 |
Why?
|
Echocardiography | 1 | 1988 | 5043 | 0.010 |
Why?
|
Diet | 1 | 2012 | 8098 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1997 | 1468 | 0.010 |
Why?
|
Levodopa | 1 | 1991 | 223 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1989 | 903 | 0.000 |
Why?
|
Infant | 1 | 1988 | 36496 | 0.000 |
Why?
|
Child, Preschool | 1 | 1988 | 42620 | 0.000 |
Why?
|
Child | 1 | 2012 | 80856 | 0.000 |
Why?
|
Adolescent | 1 | 2012 | 89163 | 0.000 |
Why?
|